Discover
ELVN
Enliven Therapeutics, Inc.
53.99
1 x 45.80
1 x 55.00
bid
ask
-
0.34
0.63%
09:32 AM
timesize
| Ytd | 250.57% | |
| 1y | 150.41% |
53.38
day range
54.70
14.79
52 week range
54.88
| Open | 53.38 | Prev Close | 54.33 | Low | 53.38 | High | 54.70 | Mkt Cap | 3.88B |
| Vol | 3.40K | Avg Vol | 1.30M | EPS | -1.67 | P/E | -32.53 | Forward P/E | -21.97 |
| Beta | 0.24 | Short Ratio | 3.49 | Inst. Own | 90.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-13 | 50-d Avg | 44.60 | 200-d Avg | 31.48 | 1yr Est | 66.00 |
| Income Statement | |||
| Operating Expenses | 27.82M | ||
| Research and Development Expense | 20.69M | ||
| Selling, General and Administrative Expense | 7.14M | ||
| Operating Income | -27.82M | ||
| Net Income | -23.63M | ||
| Net Income Common Stock | -23.63M | ||
| Net Income Common Stock (USD) | -23.63M | ||
| Consolidated Income | -23.63M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -23.63M | ||
| Earning Before Interest & Taxes (USD) | -23.63M | ||
| Weighted Average Shares | 62.80M | ||
| Weighted Average Shares Diluted | 62.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.18M | ||
| Cash and Equivalents (USD) | 132.18M | ||
| Investments | 320.22M | ||
| Investments Current | 320.22M | ||
| Current Assets | 463.14M | ||
| Property, Plant & Equipment Net | 310.00K | ||
| Total Assets | 464.85M | ||
| Current Liabilities | 11.49M | ||
| Total Liabilities | 11.49M | ||
| Accumulated Retained Earnings (Deficit) | -370.79M | ||
| Accumulated Other Comprehensive Income | -382.00K | ||
| Shareholders Equity | 453.37M | ||
| Shareholders Equity (USD) | 453.37M | ||
| Assets Non-Current | 1.72M | ||
| Trade and Non-Trade Payables | 1.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 107.00K | ||
| Net Cash Flow from Financing | 10.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.29M | ||
| Issuance (Purchase) of Equity Shares | 10.05M | ||
| Net Cash Flow from Investing | 42.53M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.53M | ||
| Net Cash Flow from Operations | -19.29M | ||
| Share Based Compensation | 7.40M | ||